Zurich Cantonal Bank’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-9,959
| Closed | -$60K | – | 2617 |
|
|
2019
Q4 | $60K | Buy |
9,959
+2,732
| +38% | +$15.8K | ﹤0.01% | 2047 |
|
|
2019
Q3 | $26K | Buy |
7,227
+4,247
| +143% | +$16.4K | ﹤0.01% | 2373 |
|
|
2019
Q2 | $8K | Hold |
2,980
| – | – | ﹤0.01% | 2585 |
|
|
2019
Q1 | $9K | Hold |
2,980
| – | – | ﹤0.01% | 2525 |
|
|
2018
Q4 | $5K | Hold |
2,980
| – | – | ﹤0.01% | 2581 |
|
|
2018
Q3 | $11K | Hold |
2,980
| – | – | ﹤0.01% | 2541 |
|
|
2018
Q2 | $8K | Hold |
2,980
| – | – | ﹤0.01% | 2513 |
|
|
2018
Q1 | $11K | Hold |
2,980
| – | – | ﹤0.01% | 2484 |
|
|
2017
Q4 | $9K | Hold |
2,980
| – | – | ﹤0.01% | 2506 |
|
|
2017
Q3 | $13K | Hold |
2,980
| – | – | ﹤0.01% | 2380 |
|
|
2017
Q2 | $14K | Hold |
2,980
| – | – | ﹤0.01% | 2364 |
|
|
2017
Q1 | $13K | Hold |
2,980
| – | – | ﹤0.01% | 2438 |
|
|
2016
Q4 | $12K | Hold |
2,980
| – | – | ﹤0.01% | 2413 |
|
|
2016
Q3 | $24K | Buy |
2,980
+665
| +29% | +$5.65K | ﹤0.01% | 2171 |
|
|
2016
Q2 | $18K | Hold |
2,315
| – | – | ﹤0.01% | 2170 |
|
|
2016
Q1 | $18K | Hold |
2,315
| – | – | ﹤0.01% | 2139 |
|
|
2015
Q4 | $25K | Buy |
2,315
+1,200
| +108% | +$10.9K | ﹤0.01% | 1902 |
|
|
2015
Q3 | $8K | Buy |
1,115
+697
| +167% | +$5.68K | ﹤0.01% | 2251 |
|
|
2015
Q2 | $4K | Hold |
418
| – | – | ﹤0.01% | 2092 |
|
|
2015
Q1 | $4K | Buy |
+418
| New | +$5.22K | ﹤0.01% | 2069 |
|
|
2014
Q2 | – | Sell |
-8,100
| Closed | -$27K | – | 1014 |
|
|
2014
Q1 | $27K | Buy |
+8,100
| New | +$28.3K | ﹤0.01% | 899 |
|
Zurich Cantonal Bank's ACHN Position: Q1 2020 in Review
Zurich Cantonal Bank sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 9,959 shares — an estimated $60K sold.
Zurich Cantonal Bank first reported a position in ACHN in Q1 2014 and held it in 21 quarters. The position peaked at $60K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Zurich Cantonal Bank reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Zurich Cantonal Bank sold 9,959 Achillion Pharmaceuticals shares in Q1 2020, an estimated $60K.
- Zurich Cantonal Bank first reported a position in Achillion Pharmaceuticals in Q1 2014 and held it in 21 quarters.
- Zurich Cantonal Bank's Achillion Pharmaceuticals position peaked at $60K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Zurich Cantonal Bank's 13F filing for Q1 2020, filed 6 May 2020.